Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Humanized Antibody 1.4.3 Human Mouse Chimeric Antibody 1.5 Market by Application 1.5.1 Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Cancer 1.5.3 Autoimmune Diseases 1.5.4 Infection 1.5.5 Hematological Diseases 1.5.6 Ophthalmological Diseases 1.5.7 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Monoclonal Antibody Therapeutics Market Perspective (2015-2026) 2.2 Monoclonal Antibody Therapeutics Growth Trends by Regions 2.2.1 Monoclonal Antibody Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Monoclonal Antibody Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Monoclonal Antibody Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Monoclonal Antibody Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Monoclonal Antibody Therapeutics Players by Market Size 3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Monoclonal Antibody Therapeutics Market Concentration Ratio 3.2.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2019 3.3 Monoclonal Antibody Therapeutics Key Players Head office and Area Served 3.4 Key Players Monoclonal Antibody Therapeutics Product Solution and Service 3.5 Date of Enter into Monoclonal Antibody Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2021-2026) 5 Monoclonal Antibody Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Monoclonal Antibody Therapeutics Market Size (2015-2020) 6.2 Monoclonal Antibody Therapeutics Key Players in North America (2019-2020) 6.3 North America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 6.4 North America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Monoclonal Antibody Therapeutics Market Size (2015-2020) 7.2 Monoclonal Antibody Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 7.4 Europe Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Monoclonal Antibody Therapeutics Market Size (2015-2020) 8.2 Monoclonal Antibody Therapeutics Key Players in China (2019-2020) 8.3 China Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 8.4 China Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Monoclonal Antibody Therapeutics Market Size (2015-2020) 9.2 Monoclonal Antibody Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 9.4 Japan Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2015-2020) 10.2 Monoclonal Antibody Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Monoclonal Antibody Therapeutics Market Size (2015-2020) 11.2 Monoclonal Antibody Therapeutics Key Players in India (2019-2020) 11.3 India Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 11.4 India Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Monoclonal Antibody Therapeutics Market Size (2015-2020) 12.2 Monoclonal Antibody Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Bayer 13.1.1 Bayer Company Details 13.1.2 Bayer Business Overview and Its Total Revenue 13.1.3 Bayer Monoclonal Antibody Therapeutics Introduction 13.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)) 13.1.5 Bayer Recent Development 13.2 F. Hoffmann-La Roche 13.2.1 F. Hoffmann-La Roche Company Details 13.2.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue 13.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction 13.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 13.2.5 F. Hoffmann-La Roche Recent Development 13.3 Pfizer 13.3.1 Pfizer Company Details 13.3.2 Pfizer Business Overview and Its Total Revenue 13.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction 13.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 13.3.5 Pfizer Recent Development 13.4 Sanofi 13.4.1 Sanofi Company Details 13.4.2 Sanofi Business Overview and Its Total Revenue 13.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction 13.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 13.4.5 Sanofi Recent Development 13.5 GlaxoSmithKline 13.5.1 GlaxoSmithKline Company Details 13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction 13.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 13.5.5 GlaxoSmithKline Recent Development 13.6 Merck 13.6.1 Merck Company Details 13.6.2 Merck Business Overview and Its Total Revenue 13.6.3 Merck Monoclonal Antibody Therapeutics Introduction 13.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 13.6.5 Merck Recent Development 13.7 Novartis 13.7.1 Novartis Company Details 13.7.2 Novartis Business Overview and Its Total Revenue 13.7.3 Novartis Monoclonal Antibody Therapeutics Introduction 13.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 13.7.5 Novartis Recent Development 13.8 AbbVie 13.8.1 AbbVie Company Details 13.8.2 AbbVie Business Overview and Its Total Revenue 13.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction 13.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 13.8.5 AbbVie Recent Development 13.9 Amgen 13.9.1 Amgen Company Details 13.9.2 Amgen Business Overview and Its Total Revenue 13.9.3 Amgen Monoclonal Antibody Therapeutics Introduction 13.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 13.9.5 Amgen Recent Development 13.10 Johnson & Johnson 13.10.1 Johnson & Johnson Company Details 13.10.2 Johnson & Johnson Business Overview and Its Total Revenue 13.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction 13.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 13.10.5 Johnson & Johnson Recent Development 13.11 Bristol-Myers Squibb Company 10.11.1 Bristol-Myers Squibb Company Company Details 10.11.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue 10.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction 10.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 10.11.5 Bristol-Myers Squibb Company Recent Development 13.12 Biogen 10.12.1 Biogen Company Details 10.12.2 Biogen Business Overview and Its Total Revenue 10.12.3 Biogen Monoclonal Antibody Therapeutics Introduction 10.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 10.12.5 Biogen Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Monoclonal Antibody Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue Table 3. Ranking of Global Top Monoclonal Antibody Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Humanized Antibody Table 6. Key Players of Human Mouse Chimeric Antibody Table 7. Global Monoclonal Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Monoclonal Antibody Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Monoclonal Antibody Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Monoclonal Antibody Therapeutics Market Share by Regions (2015-2020) Table 11. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Monoclonal Antibody Therapeutics Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Monoclonal Antibody Therapeutics Market Growth Strategy Table 17. Main Points Interviewed from Key Monoclonal Antibody Therapeutics Players Table 18. Global Monoclonal Antibody Therapeutics Revenue by Players (2015-2020) (Million US$) Table 19. Global Monoclonal Antibody Therapeutics Market Share by Players (2015-2020) Table 20. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2019) Table 21. Global Monoclonal Antibody Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Monoclonal Antibody Therapeutics Product Solution and Service Table 24. Date of Enter into Monoclonal Antibody Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (Million US$) Table 27. Global Monoclonal Antibody Therapeutics Market Size Share by Type (2015-2020) Table 28. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2015-2020) Table 30. Global Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (Million US$) Table 31. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2021-2026) Table 32. North America Key Players Monoclonal Antibody Therapeutics Revenue (2019-2020) (Million US$) Table 33. North America Key Players Monoclonal Antibody Therapeutics Market Share (2019-2020) Table 34. North America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (Million US$) Table 35. North America Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 36. North America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (Million US$) Table 37. North America Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 38. Europe Key Players Monoclonal Antibody Therapeutics Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Monoclonal Antibody Therapeutics Market Share (2019-2020) Table 40. Europe Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (Million US$) Table 41. Europe Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 42. Europe Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (Million US$) Table 43. Europe Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 44. China Key Players Monoclonal Antibody Therapeutics Revenue (2019-2020) (Million US$) Table 45. China Key Players Monoclonal Antibody Therapeutics Market Share (2019-2020) Table 46. China Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (Million US$) Table 47. China Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 48. China Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (Million US$) Table 49. China Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 50. Japan Key Players Monoclonal Antibody Therapeutics Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Monoclonal Antibody Therapeutics Market Share (2019-2020) Table 52. Japan Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (Million US$) Table 53. Japan Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 54. Japan Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (Million US$) Table 55. Japan Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Monoclonal Antibody Therapeutics Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Monoclonal Antibody Therapeutics Market Share (2019-2020) Table 58. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 60. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 62. India Key Players Monoclonal Antibody Therapeutics Revenue (2019-2020) (Million US$) Table 63. India Key Players Monoclonal Antibody Therapeutics Market Share (2019-2020) Table 64. India Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (Million US$) Table 65. India Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 66. India Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (Million US$) Table 67. India Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 68. Central & South America Key Players Monoclonal Antibody Therapeutics Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Monoclonal Antibody Therapeutics Market Share (2019-2020) Table 70. Central & South America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 72. Central & South America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 74. Bayer Company Details Table 75. Bayer Business Overview Table 76. Bayer Product Table 77. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 78. Bayer Recent Development Table 79. F. Hoffmann-La Roche Company Details Table 80. F. Hoffmann-La Roche Business Overview Table 81. F. Hoffmann-La Roche Product Table 82. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 83. F. Hoffmann-La Roche Recent Development Table 84. Pfizer Company Details Table 85. Pfizer Business Overview Table 86. Pfizer Product Table 87. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 88. Pfizer Recent Development Table 89. Sanofi Company Details Table 90. Sanofi Business Overview Table 91. Sanofi Product Table 92. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 93. Sanofi Recent Development Table 94. GlaxoSmithKline Company Details Table 95. GlaxoSmithKline Business Overview Table 96. GlaxoSmithKline Product Table 97. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 98. GlaxoSmithKline Recent Development Table 99. Merck Company Details Table 100. Merck Business Overview Table 101. Merck Product Table 102. Merck Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 103. Merck Recent Development Table 104. Novartis Company Details Table 105. Novartis Business Overview Table 106. Novartis Product Table 107. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 108. Novartis Recent Development Table 109. AbbVie Business Overview Table 110. AbbVie Product Table 111. AbbVie Company Details Table 112. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 113. AbbVie Recent Development Table 114. Amgen Company Details Table 115. Amgen Business Overview Table 116. Amgen Product Table 117. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 118. Amgen Recent Development Table 119. Johnson & Johnson Company Details Table 120. Johnson & Johnson Business Overview Table 121. Johnson & Johnson Product Table 122. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 123. Johnson & Johnson Recent Development Table 124. Bristol-Myers Squibb Company Company Details Table 125. Bristol-Myers Squibb Company Business Overview Table 126. Bristol-Myers Squibb Company Product Table 127. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 128. Bristol-Myers Squibb Company Recent Development Table 129. Biogen Company Details Table 130. Biogen Business Overview Table 131. Biogen Product Table 132. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (Million US$) Table 133. Biogen Recent Development Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Global Monoclonal Antibody Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Humanized Antibody Features Figure 3. Human Mouse Chimeric Antibody Features Figure 4. Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2026 Figure 5. Cancer Case Studies Figure 6. Autoimmune Diseases Case Studies Figure 7. Infection Case Studies Figure 8. Hematological Diseases Case Studies Figure 9. Ophthalmological Diseases Case Studies Figure 10. Others Case Studies Figure 11. Monoclonal Antibody Therapeutics Report Years Considered Figure 12. Global Monoclonal Antibody Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Monoclonal Antibody Therapeutics Market Share by Regions: 2020 VS 2026 Figure 14. Global Monoclonal Antibody Therapeutics Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Monoclonal Antibody Therapeutics Market Share by Players in 2019 Figure 17. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2019 Figure 19. North America Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 28. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 30. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 32. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 34. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 36. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 38. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 40. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 42. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 44. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 46. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 48. Biogen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Bayer F. Hoffmann-La Roche Pfizer Sanofi GlaxoSmithKline Merck Novartis AbbVie Amgen Johnson & Johnson Bristol-Myers Squibb Company Biogen